Roivant to Present at Upcoming Investor Conferences
January 25, 2022 16:30 ET
|
Roivant Sciences
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that its CEO Matt Gline will present at two upcoming...
Roivant Licenses Splicing Modulator and Announces Upcoming Presentation at 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 16:30 ET
|
Roivant Sciences
Roivant will develop RVT-2001 for the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromesRoivant JPM presentation scheduled for Monday, January 10, at 2:15...
Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update
November 15, 2021 07:00 ET
|
Roivant Sciences, Inc.
Roivant began trading on Nasdaq under “ROIV”; cash balance increased to $2.5 billion.Dermavant announced final results from the Phase 3 PSOARING 3 long-term extension study of tapinarof in patients...
Roivant to Report Financial Results for the Quarter Ended September 30, 2021 on Monday, November 15, 2021
November 08, 2021 16:45 ET
|
Roivant Sciences, Inc.
Quarterly investor call and webcast scheduled on Monday, November 15th at 8:00am ETRoivant will also present at the Jefferies London Healthcare and Evercore ISI HealthCONx investor conferences in...
Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing
October 01, 2021 08:00 ET
|
Roivant Sciences, Inc.
Roivant will begin trading on Nasdaq under the ticker “ROIV” later todayR&D Day presentations from September 28th highlighting Roivant’s pipeline and discovery platform available on Roivant’s...
Roivant Acquires SB742457 From GlaxoSmithKline
December 23, 2014 09:00 ET
|
Roivant Sciences, Inc.
-Roivant intends to commence Phase 3 clinical trials in Alzheimer's disease in 2015-
-Development led by the developer of Alzheimer's medicine, Aricept-
HAMILTON, Bermuda, Dec. 23, 2014 (GLOBE...